Handbook of perinatal infections, J. L. Sever, J. W. Larsen, Jr., and J. H. Grossman III, Little, Brown and Co., Boston, 1979, 199 pp

No Abstract.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/38149/1/1420230317_ftp.pd

A Controlled Trial of Intravenous Immune Globulin to Reduce Nosocomial Infections in Very-Low-Birth-Weight Infants

Although survival rates for very-low-birth-weight infants ( ≤ 1.5 kg) continue to increase, 1 nosocomial infections remain a major cause of morbidity and mortality. Prolonged hospitalization with exposure to resistant organisms and multiple invasive procedures, in the presence of immunologic immaturity, 2 renders these infants vulnerable to hospital-acquired infections 3 . Profound hypogammaglobulinemia may result from low levels of IgG at birth (IgG is largely acquired transplacentally in the latter half of the third trimester), degradation of maternally acquired IgG, and delayed production of IgG after birth 4 . The use of pooled IgG has been suggested as a possible means of reducing this . . 

Gastrointestinal Stromal Tumor Masquerading as a Spontaneous Rectal Hematoma

A 78-year-old Caucasian male with a history of atrial fibrillation and anticoagulation with warfarin presented with a change in bowel habits and weight loss. A computed tomography (CT) scan showed a 3.5 cm rectal mass. After biopsy with colonoscopy and endoscopic ultrasonography, the rectal mass was highly suspicious for rectal hematoma. When the rectal mass did not resolve after 1 month of follow-up, surgery showed the patient to have a rectal gastrointestinal stromal tumor. He is being treated with imatinib and follow-up CT scans. This case illustrates the importance of a high level of suspicion for a gastrointestinal stromal tumor when a rectal mass is found